Justin M Welch

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Doripenem is the latest carbapenem on the market to date. Although not an antibiotic in a new class, it offers a glimmer of hope in combating serious infections secondary to multidrug-resistant Gram-negative bacteria when we have not seen a new class of antibacterial, particularly for Gram-negative bacteria, for more than 10 years. In vitro, doripenem(More)
  • 1